|
Acne may be cured by a simple light treatment, first developed to iron out wrinkles, as demonstrated a study carried out at a London hospital. The Hammersmith Hospital in West London tested Low Level Laser Therapy normally used in private beauty salons on 30 patients who were suffering mild to moderate acne. In a period of 12 weeks their acne had halved. Meanwhile, those on a dummy treatment showed no improvement. Findings show that those with the most severe symptoms displayed the most astonishing improvement, mostly within the first month of treatment. Under experts conclusions, this is significantly faster than most conventional antibiotic treatments, which can take as long as eight months to work. The study showed that a single five-minute session could have a dramatic effect on acne for up to 12 months. Physicians used a treatment called pulse dye laser therapy in which the affected area is exposed to short bursts of light. The process had been used to combat wrinkles as it is known to stimulate the production of collagen. Tony Chu, the dermatologist who led the trial, explained that "we were brought in to see if the anecdotal evidence worked in a clinical trial and we found out it was very successful. However, we still do not know exactly how it works and that is an area we are now working on." The expert said that the treatment appears to be showing the same kind of efficacy as antibiotics, but without the potential side effects. "What we need to do now is to see if it works as well on acne around other parts of the body, and work out the treatment which is most clinically effective", stated. Article written by Hector Milla, editor of http://www.acnetreatmentstips.com , a website pointing acne treatment tips and http://www.acnesolutionsproducts.com , visit for reviews and acne solution products information . Thanks for use this article in your website or ezine keeping a live link. Acne: FDA Approved Aczone For Acne Treatment The U.S. Food and Drug Administration (FDA) approved to market Aczone (dapsone) Gel, 5 per cent for acne vulgaris topical treatment. But patients who have the enzyme deficiency, G6PD (Glucose 6-phosphate dehydrogenase), will need to be monitored with regular blood counts to detect if they are predisposed to one type of anemia (hemolytic anemia). Aczone, a trademark of QLT USA Inc., is an aqueous topical gel which contains 5 per cent dapsone. According to scientific research, combining dapsone in a Solvent Microparticulate (SMP) gel enables dapsone to be applied topically and safely. This product achieved significant per cent reduction in the number of acne lesions and better success rate on the Global Acne Assessment Score in two randomized double-blind, vehicle controlled clinical studies in 3000 acne patients. Oiliness/peeling, dryness, and erythema were the most common adverse events reported from controlled clinical trials. However, there were no significant differences in the adverse event rates between Aczone Gel and vehicle control treated patients. 1.4 per cent of about 3500 patients had the enzyme deficiency -in the Aczone clinical trial program- which is consistent with the incidence in the general North American population. The company QLT will undertake a post-approval Phase IV study in 50 acne patients who have G6PD deficiency and follow them for 6 months, after which QLT expects to submit an application to the FDA to re-evaluate the Aczone label. The President and Chief Executive Officer of QLT Inc., Paul Hastings, stated that "Aczone represents an important clinical advance in dermatology, has demonstrated safety and efficacy in over 4,000 patients. We are very pleased with the FDA's decision and confident in Aczone's potential as a new class of treatment for acne patients". Did You Know That the First Step to Living Acne Free Is Understanding It's Underlying Causes? Best Acne products Clear Skin Max Review Sven Hyltén-Cavallius
Related Articles -
acne treatments, acne solutions products,
| 
